News
Here you will find financial news from APONTIS PHARMA as well as other publications relevant to the capital market.
Latest News
Ad-hoc News
13.06.2025 |
APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
APONTIS PHARMA AG / Key word(s): Squeeze Out APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at...
Ad-hoc News
13.06.2025 | EQS-Ad-hoc
APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
APONTIS PHARMA AG/ Key word(s): Squeeze Out APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at...
Corporate News
15.05.2025 |
APONTIS PHARMA ver\u00f6ffentlicht Ergebnisse des ersten Quartals 2025 und best\u00e4tigt Prognose...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis APONTIS PHARMA...
Corporate News
15.05.2025 | EQS-News
APONTIS PHARMA publishes results for the first quarter of 2025 and confirms forecast for 2025
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/Quarter Results APONTIS PHARMA publishes...
Corporate News
31.03.2025 |
APONTIS PHARMA mit deutlichem Anstieg von Umsatz und Ergebnis im Gesch\u00e4ftsjahr 2024 \u2013...
APONTIS PHARMA AG / Schlagwort(e): Jahresbericht/Jahresergebnis APONTIS PHARMA mit deutlichem Anstieg von...
Corporate News
31.03.2025 | EQS-News
APONTIS PHARMA with significant sales and earnings increase in 2024 financial year – squeeze-out...
EQS-News: APONTIS PHARMA AG/ Key word(s): Annual Report/Annual Results APONTIS PHARMA with significant sales and...
Ad-hoc News
05.03.2025 | EQS-Ad-hoc
APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the...
APONTIS PHARMA AG/ Key word(s): Squeeze Out APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a...
Ad-hoc News
05.03.2025 |
APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a merger squeeze-out of the...
APONTIS PHARMA AG / Key word(s): Squeeze Out APONTIS PHARMA AG: Zentiva AG submits formal request to carry out a...
Directors' Dealings
11.12.2024 |
Thomas Milz
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
11.12.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, Sale: The sale was made via a joint custody account with Ariane...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Thomas Milz
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, Sale: The sale was made via a joint custody account with Ariane...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Karin Wohlschlegel
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Karin Wohlschlegel, sell
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
be executive GmbH
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: be executive GmbH, sell
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, sell
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 |
Olaf Elbracht
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
10.12.2024 | EQS-DD
APONTIS PHARMA AG: Olaf Elbracht, Sale: The sale was made via a joint securities account with...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Corporate News
21.11.2024 |
APONTIS PHARMA AG: Verzicht auf die Bedingung der Mindestannahme im freiwilligen \u00f6ffentlichen...
APONTIS PHARMA AG / Schlagwort(e): \u00dcbernahmeangebot APONTIS PHARMA AG: Verzicht auf die Bedingung der...
Corporate News
21.11.2024 | EQS-News
APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
EQS-News: APONTIS PHARMA AG/ Key word(s): Tender Offer APONTIS PHARMA AG: Condition of Minimum Acceptance in...
Corporate News
07.11.2024 |
APONTIS PHARMA mit profitablem Umsatzwachstum bei Single Pill-Kombinationen in 9M 2024 \u2013...
APONTIS PHARMA AG / Schlagwort(e): 9-Monatszahlen/Prognose\u00e4nderung APONTIS PHARMA mit profitablem...
Corporate News
07.11.2024 | EQS-News
APONTIS PHARMA reports profitable revenue growth for Single Pill combinations in 9M 2024 – revenue...
EQS-News: APONTIS PHARMA AG/ Key word(s): 9 Month figures/Change in Forecast APONTIS PHARMA reports profitable...
Corporate News
30.10.2024 |
Vorstand und Aufsichtsrat der APONTIS PHARMA AG empfehlen Annahme des \u00f6ffentlichen...
APONTIS PHARMA AG / Schlagwort(e): \u00dcbernahmeangebot/Stellungnahme Vorstand und Aufsichtsrat der APONTIS...
Corporate News
30.10.2024 | EQS-News
Management Board and Supervisory Board of APONTIS PHARMA AG recommend accepting Zentiva’s public...
EQS-News: APONTIS PHARMA AG/ Key word(s): Tender Offer/Statement Management Board and Supervisory Board of APONTIS...
Corporate News
16.10.2024 |
APONTIS PHARMA und Zentiva schlie\u00dfen Partnerschaft f\u00fcr zuk\u00fcnftiges Wachstum \u2013...
APONTIS PHARMA AG / Schlagwort(e): \u00dcbernahmeangebot APONTIS PHARMA und Zentiva schlie\u00dfen...
Corporate News
16.10.2024 | EQS-News
APONTIS PHARMA and Zentiva entered into partnership for future growth – Zentiva will launch a...
EQS-News: APONTIS PHARMA AG/ Key word(s): Tender Offer APONTIS PHARMA and Zentiva entered into partnership for...
Ad-hoc News
16.10.2024 |
APONTIS PHARMA and Zentiva enter into investment agreement \u2013 Zentiva will launch a voluntary...
APONTIS PHARMA AG / Key word(s): Tender Offer APONTIS PHARMA and Zentiva enter into investment agreement \u2013...
Ad-hoc News
16.10.2024 | EQS-Ad-hoc
APONTIS PHARMA and Zentiva enter into investment agreement – Zentiva will launch a voluntary public...
APONTIS PHARMA AG/ Key word(s): Tender Offer APONTIS PHARMA and Zentiva enter into investment agreement– Zentiva...
Corporate News
09.08.2024 |
APONTIS PHARMA mit profitablem Umsatzwachstum bei Single Pill-Kombinationen im ersten Halbjahr 2024...
APONTIS PHARMA AG / Schlagwort(e): Halbjahresbericht/Halbjahresergebnis APONTIS PHARMA mit profitablem...
Corporate News
09.08.2024 | EQS-News
APONTIS PHARMA with profitable revenue growth for Single Pill combinations in the first half of...
EQS-News: APONTIS PHARMA AG/ Key word(s): Half Year Report/Half Year Results APONTIS PHARMA with profitable revenue...
Corporate News
27.06.2024 |
APONTIS PHARMA AG beruft mit Blick auf die strategische Weiterentwicklung des Unternehmens CFO...
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA AG beruft mit Blick auf die strategische...
Corporate News
27.06.2024 | EQS-News
APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the Management Board with a view to the...
EQS-News: APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA AG appoints CFO Thomas Zimmermann to the...
Corporate News
04.06.2024 | EQS-News
APONTIS PHARMA continues to gear organization towards growth and internationalization – Renowned...
EQS-News: APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA continues to gear organization towards growth and...
Corporate News
04.06.2024 |
APONTIS PHARMA richtet Organisation weiter gezielt auf Wachstum und Internationalisierung aus...
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA richtet Organisation weiter gezielt auf...
Directors' Dealings
14.05.2024 |
Thomas Milz
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
14.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
14.05.2024 |
be executive GmbH
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
14.05.2024 | EQS-DD
APONTIS PHARMA AG: be executive GmbH, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 |
Thomas Zimmermann
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
13.05.2024 | EQS-DD
APONTIS PHARMA AG: Thomas Zimmermann, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Corporate News
08.05.2024 | EQS-News
APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and...
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/Quarter Results APONTIS PHARMA starts...
Corporate News
08.05.2024 |
APONTIS PHARMA startet mit Umsatzwachstum bei Single Pill-Kombinationen und positivem Nettoergebnis...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/Quartalsergebnis APONTIS PHARMA startet mit...
Corporate News
05.04.2024 | EQS-News
APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma...
EQS-News: APONTIS PHARMA AG/ Key word(s): Change in Forecast/Alliance APONTIS PHARMA enters five-year distribution...
Corporate News
05.04.2024 |
APONTIS PHARMA schlie\u00dft f\u00fcnfj\u00e4hrige Distributions- und Vermarktungsvereinbarung...
APONTIS PHARMA AG / Schlagwort(e): Prognose\u00e4nderung/Kooperation APONTIS PHARMA schlie\u00dft...
Ad-hoc News
05.04.2024 | EQS-Ad-hoc
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement...
APONTIS PHARMA AG/ Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG raises forecast after entering...
Ad-hoc News
05.04.2024 | EQS-Ad-hoc
APONTIS PHARMA AG raises forecast after entering five-year distribution and marketing agreement...
APONTIS PHARMA AG / Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG raises forecast after entering...
Corporate News
28.03.2024 | EQS-News
APONTIS PHARMA expects profitable growth again in 2024
EQS-News: APONTIS PHARMA AG/ Key word(s): Annual Results/Annual Report APONTIS PHARMA expects profitable growth...
Corporate News
28.03.2024 |
APONTIS PHARMA erwartet 2024 wieder profitables Wachstum
APONTIS PHARMA AG / Schlagwort(e): Jahresergebnis/Jahresbericht APONTIS PHARMA erwartet 2024 wieder...
Corporate News
06.02.2024 | EQS-News
APONTIS PHARMA successfully completes performance and efficiency improvement program
EQS-News: APONTIS PHARMA AG/ Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA...
Corporate News
06.02.2024 |
APONTIS PHARMA schlie\u00dft Performance- und Effizienzsteigerungsprogramm erfolgreich ab
APONTIS PHARMA AG / Schlagwort(e): Strategische Unternehmensentscheidung/Unternehmensrestrukturierung...
Corporate News
09.11.2023 | EQS-News
APONTIS PHARMA presents details of the restructuring and efficiency program – Nine-month figures...
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/9 Month figures APONTIS PHARMA presents...
Corporate News
09.11.2023 |
APONTIS PHARMA stellt Details des Restrukturierungs- und Effizienzprogramms vor \u2013...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen APONTIS PHARMA stellt Details...
Ad-hoc News
08.11.2023 | EQS-Ad-hoc
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
APONTIS PHARMA AG/ Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA AG with new...
Ad-hoc News
08.11.2023 |
APONTIS PHARMA AG with new forecast 2023 and details on announced restructuring program
APONTIS PHARMA AG / Key word(s): Strategic Company Decision/Restructure of Company APONTIS PHARMA AG with new...
Corporate News
10.08.2023 | EQS-News
APONTIS PHARMA confirms preliminary figures – H1 2023 sales and earnings decline
EQS-News: APONTIS PHARMA AG/ Key word(s): Half Year Results/Half Year Report APONTIS PHARMA confirms preliminary...
Corporate News
10.08.2023 |
APONTIS PHARMA best\u00e4tigt vorl\u00e4ufige Zahlen \u2013 1. Halbjahr 2023 mit Umsatz- und...
APONTIS PHARMA AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht APONTIS PHARMA best\u00e4tigt...
Ad-hoc News
31.07.2023 | EQS-Ad-hoc
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024
APONTIS PHARMA AG/ Key word(s): Contract APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued...
Ad-hoc News
31.07.2023 |
APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be continued in 2024
APONTIS PHARMA AG / Key word(s): Contract APONTIS PHARMA: Co-promotion contract with AstraZeneca not to be...
Corporate News
27.07.2023 |
APONTIS PHARMA AG nimmt Prognose f\u00fcr Gesch\u00e4ftsjahr 2023 sowie Mittelfristplanung f\u00fcr...
APONTIS PHARMA AG / Schlagwort(e): Prognose\u00e4nderung/Gewinnwarnung APONTIS PHARMA AG nimmt Prognose...
Corporate News
27.07.2023 | EQS-News
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026 –...
EQS-News: APONTIS PHARMA AG/ Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for...
Ad-hoc News
27.07.2023 |
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026
APONTIS PHARMA AG / Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for fiscal...
Ad-hoc News
27.07.2023 | EQS-Ad-hoc
APONTIS PHARMA AG withdraws forecast for fiscal year 2023 and medium-term planning for 2026
APONTIS PHARMA AG/ Key word(s): Change in Forecast/Profit Warning APONTIS PHARMA AG withdraws forecast for fiscal...
Corporate News
10.07.2023 |
APONTIS PHARMA: Vorstandsvorsitzender Karlheinz Gast legt Amt aus pers\u00f6nlichen Gr\u00fcnden...
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA: Vorstandsvorsitzender Karlheinz Gast legt Amt...
Corporate News
10.07.2023 | EQS-News
APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons - Bruno Wohlschlegel takes over as...
EQS-News: APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA: CEO Karlheinz Gast resigns for personal reasons-...
Ad-hoc News
10.07.2023 | EQS-Ad-hoc
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
APONTIS PHARMA AG/ Key word(s): Personnel APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal...
Ad-hoc News
10.07.2023 |
APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal reasons
APONTIS PHARMA AG / Key word(s): Personnel APONTIS PHARMA AG: CEO Karlheinz Gast resigns from office for personal...
Corporate News
29.06.2023 |
APONTIS PHARMA startet Single Pill Finder und Vertrieb f\u00fcr Single Pill Rosazimib \u2013 Erste...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA startet Single Pill Finder und...
Corporate News
29.06.2023 | EQS-News
APONTIS PHARMA launches Single Pill Finder and distribution of Single Pill Rosazimib - First of...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA launches Single Pill Finder and distribution...
Corporate News
09.05.2023 |
APONTIS PHARMA in Q1 2023 mit erwartetem Umsatz- und Ergebnisr\u00fcckgang \u2013 2023 als...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung APONTIS PHARMA in Q1 2023 mit erwartetem...
Corporate News
09.05.2023 | EQS-News
APONTIS PHARMA in Q1 2023 records decline in sales and earnings as expected – 2023 as a transition...
EQS-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement APONTIS PHARMA in Q1 2023 records decline in...
Corporate News
08.05.2023 |
APONTIS PHARMA: Anhaltend hohe Geschwindigkeit bei Ausbau des Single Pill-Portfolios \u2014 Neue...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA: Anhaltend hohe Geschwindigkeit bei...
Corporate News
08.05.2023 | EQS-News
APONTIS PHARMA: Keeping up high pace in expansion of Single Pill portfolio - New development...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: Keeping up high pace in expansion of Single...
Directors' Dealings
05.05.2023 |
Silke Reineke
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
05.05.2023 | EQS-DD
APONTIS PHARMA AG: Silke Reineke, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
05.05.2023 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Directors' Dealings
05.05.2023 | EQS-DD
APONTIS PHARMA AG: Thomas Milz, buy
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons...
Ad-hoc News
02.05.2023 | EQS-Ad-hoc
APONTIS PHARMA AG adjusts forecast for fiscal year 2023
APONTIS PHARMA AG/ Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG adjusts forecast for fiscal year 2023...
Ad-hoc News
02.05.2023 |
APONTIS PHARMA AG adjusts forecast for fiscal year 2023
APONTIS PHARMA AG / Key word(s): Forecast/Change in Forecast APONTIS PHARMA AG adjusts forecast for fiscal year...
Corporate News
27.04.2023 |
APONTIS PHARMA mit erster Einlizenzierung einer Single Pill mit zwei Wirkstoffen zur...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA mit erster Einlizenzierung einer...
Corporate News
27.04.2023 | EQS-News
APONTIS PHARMA with first in-licensing of a Single Pill with two active ingredients for the primary...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA with first in-licensing of a Single Pill...
Corporate News
12.04.2023 | EQS-News
APONTIS PHARMA: New development partnership with Midas Pharma – Expansion of Single Pill portfolio...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: New development partnership with Midas...
Corporate News
12.04.2023 |
APONTIS PHARMA: Neue Entwicklungspartnerschaft mit Midas Pharma \u2013 Erweiterung des Single...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA: Neue Entwicklungspartnerschaft mit...
Corporate News
09.03.2023 | EQS-News
APONTIS PHARMA with successful financial year 2022: Revenue and EBITDA forecast slightly exceeded...
EQS-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Annual Results APONTIS PHARMA with successful...
Corporate News
09.03.2023 |
APONTIS PHARMA mit erfolgreichem Gesch\u00e4ftsjahr 2022: Umsatz- und EBITDA-Prognose nach...
APONTIS PHARMA AG / Schlagwort(e): Vorl\u00e4ufiges Ergebnis/Jahresergebnis APONTIS PHARMA mit erfolgreichem...
Corporate News
14.02.2023 |
APONTIS PHARMA beschleunigt Ausbau des Single Pill-Portfolios mit zweiter von drei f\u00fcr 2023...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA beschleunigt Ausbau des Single...
Corporate News
14.02.2023 | EQS-News
APONTIS PHARMA accelerates expansion of Single Pill portfolio with second of three in-licensing...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA accelerates expansion of Single Pill...
Corporate News
31.01.2023 | EQS-News
APONTIS PHARMA extends portfolio for the treatment of hypertension and hyperlipidemia by...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA extends portfolio for the treatment of...
Corporate News
31.01.2023 |
APONTIS PHARMA erweitert Portfolio zur Behandlung von Hypertonie und Hyperlipid\u00e4mie durch...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA erweitert Portfolio zur Behandlung...
Corporate News
29.11.2022 | EQS-News
APONTIS PHARMA: Number of announced market launches increases to ten Single Pills – Portfolio grows...
EQS-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA: Number of announced market launches...
Corporate News
29.11.2022 |
APONTIS PHARMA: Anzahl der angek\u00fcndigten Markteinf\u00fchrungen steigt auf zehn Single Pills...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA: Anzahl der angek\u00fcndigten...
Corporate News
10.11.2022 |
APONTIS PHARMA best\u00e4tigt Prognose 2022 nach erfolgreichem Neun-Monatszeitraum \u2013 Starke...
APONTIS PHARMA AG / Schlagwort(e): 9-Monatszahlen/Quartals-/Zwischenmitteilung APONTIS PHARMA best\u00e4tigt...
Corporate News
10.11.2022 | EQS-News
APONTIS PHARMA confirms 2022 forecast after successful nine-month period – Strong Single Pill...
EQS-News: APONTIS PHARMA AG/ Key word(s): 9 Month figures/Quarterly/ Interim Statement APONTIS PHARMA confirms 2022...
Corporate News
20.09.2022 |
APONTIS PHARMA gibt Kooperation zur Markteinf\u00fchrung einer neuen Single Pill in Deutschland...
APONTIS PHARMA AG / Schlagwort(e): Kooperation/Produkteinf\u00fchrung APONTIS PHARMA gibt Kooperation zur...
Corporate News
20.09.2022 | EQS-News
APONTIS PHARMA announces cooperation to launch new Single Pill in Germany
EQS-News: APONTIS PHARMA AG/ Key word(s): Alliance/Product Launch APONTIS PHARMA announces cooperation to launch new...
Corporate News
01.09.2022 |
APONTIS PHARMA: SECURE-Studie und START-Studie-Zusatzanalyse best\u00e4tigen \u00fcberlegene...
APONTIS PHARMA AG / Schlagwort(e): Wissenschaftl. Publikation APONTIS PHARMA: SECURE-Studie und...
Corporate News
01.09.2022 | DGAP-News
APONTIS PHARMA: SECURE study and START study add-on analysis confirm superior efficacy of Single Pill
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication APONTIS PHARMA: SECURE study and START study...
Corporate News
11.08.2022 |
APONTIS PHARMA baut profitable Positionierung in H1\u00a02022 aus \u2013 Prognose f\u00fcr...
APONTIS PHARMA AG / Schlagwort(e): Halbjahresbericht/Halbjahresergebnis APONTIS PHARMA baut profitable...
Corporate News
11.08.2022 | DGAP-News
APONTIS PHARMA expands profitable positioning in first half of 2022 – full-year forecast confirmed
DGAP-News: APONTIS PHARMA AG/ Key word(s): Half Year Report/Half Year Results APONTIS PHARMA expands profitable...
Corporate News
19.07.2022 | DGAP-News
APONTIS PHARMA and Midas Pharma agree on further development partnership for the market launch of a...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance/Market launch APONTIS PHARMA and Midas Pharma agree on further...
Corporate News
19.07.2022 |
APONTIS PHARMA und Midas Pharma vereinbaren weitere Entwicklungspartnerschaft zur...
APONTIS PHARMA AG / Schlagwort(e): Kooperation/Markteinf\u00fchrung APONTIS PHARMA und Midas Pharma...
Corporate News
06.07.2022 | DGAP-News
APONTIS PHARMA rolls out new Single Pill for secondary prophylaxis
DGAP-News: APONTIS PHARMA AG/ Key word(s): Market launch APONTIS PHARMA rolls out new Single Pill for secondary...
Corporate News
06.07.2022 |
APONTIS PHARMA f\u00fchrt eine neue Single Pill zur Sekund\u00e4rprophylaxe in den Markt ein
APONTIS PHARMA AG / Schlagwort(e): Markteinf\u00fchrung APONTIS PHARMA f\u00fchrt eine neue Single Pill zur...
Corporate News
23.06.2022 | DGAP-News
APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG/ Key word(s): Share Buyback APONTIS PHARMA AG: Notice according to Article 2 paragraph...
Corporate News
23.06.2022 |
APONTIS PHARMA AG: Bekanntmachung gem\u00e4\u00df Art. 2 Abs. 1 der Delegierten Verordnung (EU)...
APONTIS PHARMA AG / Schlagwort(e): Aktienr\u00fcckkauf APONTIS PHARMA AG: Bekanntmachung gem\u00e4\u00df...
Corporate News
25.05.2022 | DGAP-News
APONTIS PHARMA launches two new single pills - medium-term revenue potential of EUR 8.2 million
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA launches two new single pills- medium-term...
Corporate News
25.05.2022 |
APONTIS PHARMA f\u00fchrt zwei neue Single Pills in den Markt ein \u2013 mittelfristiges...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA f\u00fchrt zwei neue Single Pills...
Corporate News
12.05.2022 | DGAP-News
APONTIS PHARMA holds Annual General Meeting 2022 - shareholders approve all agenda items with large...
DGAP-News: APONTIS PHARMA AG/ Key word(s): AGM/EGM APONTIS PHARMA holds Annual General Meeting 2022- shareholders...
Corporate News
12.05.2022 | DGAP-News
APONTIS PHARMA f\u00fchrt ordentliche Hauptversammlung 2022 durch \u2013 Aktion\u00e4re stimmen...
APONTIS PHARMA AG / Schlagwort(e): Hauptversammlung APONTIS PHARMA f\u00fchrt ordentliche Hauptversammlung...
Corporate News
10.05.2022 | DGAP-News
APONTIS PHARMA continues strong profitable growth in Q1 2022
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement APONTIS PHARMA continues strong profitable...
Corporate News
10.05.2022 |
APONTIS PHARMA mit anhaltend starkem profitablem Wachstum im ersten Quartal 2022
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung APONTIS PHARMA mit anhaltend starkem...
Corporate News
05.05.2022 | DGAP-News
APONTIS PHARMA and Develco Pharma enter development partnership for launch of two Single Pills with...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch APONTIS PHARMA and Develco Pharma enter development...
Corporate News
05.05.2022 |
APONTIS PHARMA und Develco Pharma schlie\u00dfen Entwicklungspartnerschaft zur Markteinf\u00fchrung...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA und Develco Pharma schlie\u00dfen...
Corporate News
20.04.2022 | DGAP-News
APONTIS PHARMA: START study published in scientific journal - Cost reduction in the treatment of...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication APONTIS PHARMA: START study published in...
Corporate News
20.04.2022 |
APONTIS PHARMA: START-Studie in wissenschaftlicher Publikation ver\u00f6ffentlicht -...
APONTIS PHARMA AG / Schlagwort(e): Wissenschaftl. Publikation APONTIS PHARMA: START-Studie in...
Corporate News
16.03.2022 |
APONTIS PHARMA: START-Studie in wissenschaftlicher Publikation ver\u00f6ffentlicht - Geringeres...
APONTIS PHARMA AG / Schlagwort(e): Wissenschaftl. Publikation APONTIS PHARMA: START-Studie in...
Corporate News
16.03.2022 | DGAP-News
APONTIS PHARMA: START study published in scientific journal - Lower incidence of cardiovascular...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Scientific publication 16.03.2022/ 07:30 The issuer is solely responsible...
Corporate News
15.03.2022 |
APONTIS PHARMA AG: Bekanntmachung gem\u00e4\u00df Art. 2 Abs. 1 der Delegierten Verordnung (EU)...
APONTIS PHARMA AG / Schlagwort(e): Aktienr\u00fcckkauf APONTIS PHARMA AG: Bekanntmachung gem\u00e4\u00df...
Corporate News
15.03.2022 | DGAP-News
APONTIS PHARMA AG: Notice according to Article 2 paragraph 1 of Delegated Regulation (EU) 2016/1052
DGAP-News: APONTIS PHARMA AG/ Key word(s): Share Buyback 15.03.2022/ 07:30 The issuer is solely responsible for the...
Corporate News
08.03.2022 |
APONTIS PHARMA und AstraZeneca verl\u00e4ngern strategische Vertriebskooperation
APONTIS PHARMA AG / Schlagwort(e): Kooperation APONTIS PHARMA und AstraZeneca verl\u00e4ngern strategische...
Corporate News
08.03.2022 | DGAP-News
APONTIS PHARMA and AstraZeneca extend strategic sales cooperation
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance 08.03.2022/ 07:30 The issuer is solely responsible for the...
Corporate News
03.03.2022 |
APONTIS PHARMA mit erfolgreichem Gesch\u00e4ftsjahr 2021 - Single Pills als Wachstumstreiber
APONTIS PHARMA AG / Schlagwort(e): Vorl\u00e4ufiges Ergebnis/Jahresergebnis APONTIS PHARMA mit erfolgreichem...
Corporate News
03.03.2022 | DGAP-News
APONTIS PHARMA reports successful financial year 2021 - Single Pills as growth driver
DGAP-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Annual Results 03.03.2022/ 07:30 The issuer is solely...
Corporate News
16.12.2021 |
APONTIS PHARMA erweitert Management f\u00fcr k\u00fcnftiges Wachstum: Thomas Zimmermann wird neuer CFO
APONTIS PHARMA AG / Schlagwort(e): Personalie APONTIS PHARMA erweitert Management f\u00fcr k\u00fcnftiges...
Corporate News
16.12.2021 | DGAP-News
APONTIS PHARMA strengthens management for future growth: Thomas Zimmermann appointed new CFO
DGAP-News: APONTIS PHARMA AG/ Key word(s): Personnel 16.12.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.12.2021 |
APONTIS PHARMA und Midas Pharma geben Entwicklungspartnerschaft zur Markteinf\u00fchrung einer...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung/Kooperation APONTIS PHARMA und Midas Pharma geben...
Corporate News
14.12.2021 | DGAP-News
APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch/Alliance 14.12.2021/ 07:30 The issuer is solely...
Corporate News
18.11.2021 |
APONTIS PHARMA w\u00e4chst im 9-Monatszeitraum 2021 deutlich schneller als der Gesamtmarkt -...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung/9-Monatszahlen APONTIS PHARMA w\u00e4chst im...
Corporate News
18.11.2021 | DGAP-News
APONTIS PHARMA grows significantly faster than the overall market in the nine-month period 2021 -...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement/9 Month figures 18.11.2021/ 07:30 The issuer...
Corporate News
26.10.2021 |
APONTIS PHARMA gibt Markteinf\u00fchrung einer neuen Single Pill bekannt
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA gibt Markteinf\u00fchrung einer...
Corporate News
26.10.2021 | DGAP-News
APONTIS PHARMA announces market launch of new Single Pill
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch 26.10.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.09.2021 | DGAP-News
APONTIS PHARMA announces launch of new Single Pill for more efficient treatment of hypertension and...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Product Launch 14.09.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
14.09.2021 |
APONTIS PHARMA gibt Markteinf\u00fchrung einer neuen Single Pill zur effizienteren Behandlung von...
APONTIS PHARMA AG / Schlagwort(e): Produkteinf\u00fchrung APONTIS PHARMA gibt Markteinf\u00fchrung einer...
Corporate News
11.08.2021 | DGAP-News
APONTIS PHARMA builds on strong position and profitability in first half of 2021 - preliminary...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Half Year Results/Half Year Report 11.08.2021/ 07:30 The issuer is solely...
Corporate News
11.08.2021 |
APONTIS PHARMA baut starke Position und Profitabilit\u00e4t in H1 2021 aus - Vorl\u00e4ufige Zahlen...
APONTIS PHARMA AG / Schlagwort(e): Halbjahresergebnis/Halbjahresbericht APONTIS PHARMA baut starke Position...
Corporate News
28.07.2021 | DGAP-News
APONTIS PHARMA reports accelerated growth in first half of 2021 - Single Pill revenues +83% to EUR...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Preliminary Results/Half Year Results 28.07.2021/ 07:30 The issuer is...
Corporate News
28.07.2021 |
APONTIS PHARMA mit beschleunigtem Wachstum in H1 2021 - Umsatz mit Single Pills +83 % auf EUR 14,0...
APONTIS PHARMA AG / Schlagwort(e): Vorl\u00e4ufiges Ergebnis/Halbjahresergebnis APONTIS PHARMA mit...
Corporate News
12.07.2021 | DGAP-News
APONTIS PHARMA marks further success in the roll-out of Single Pill therapy
DGAP-News: APONTIS PHARMA AG/ Key word(s): Alliance 12.07.2021/ 07:30 The issuer is solely responsible for the...
Corporate News
12.07.2021 |
APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der Single Pill-Therapie
APONTIS PHARMA AG / Schlagwort(e): Kooperation APONTIS PHARMA feiert weiteren Erfolg in der Verbreitung der...
Corporate News
18.06.2021 | DGAP-News
APONTIS PHARMA AG: Initial studies confirm that the share has a price potential of between 77% and...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Research Update 18.06.2021/ 07:30 The issuer is solely responsible for...
Corporate News
18.06.2021 |
APONTIS PHARMA AG: Initial-Studien bescheinigen der Aktie zwischen 77 % und 135 % Kurspotenzial
APONTIS PHARMA AG / Schlagwort(e): Research Update APONTIS PHARMA AG: Initial-Studien bescheinigen der Aktie...
Corporate News
10.06.2021 | DGAP-News
APONTIS PHARMA AG: Post-Stabilisation disclosure - Partial exercise of the Greenshoe Option
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 10.06.2021/ 21:23 The issuer is solely responsible for the...
Corporate News
10.06.2021 |
APONTIS PHARMA AG: Post-Stabilisierungsmitteilung - Teilweise Aus\u00fcbung der Greenshoe-Option
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Post-Stabilisierungsmitteilung - Teilweise...
Corporate News
10.06.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 10.06.2021/ 21:20 The issuer is solely responsible for the...
Corporate News
10.06.2021 |
APONTIS PHARMA AG: Bekanntmachung \u00fcber die Durchf\u00fchrung von Stabilisierungsma\u00dfnahmen
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Bekanntmachung \u00fcber die...
Corporate News
28.05.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 28.05.2021/ 20:05 The issuer is solely responsible for the...
Corporate News
28.05.2021 |
APONTIS PHARMA AG: Bekanntmachung \u00fcber die Durchf\u00fchrung von Stabilisierungsma\u00dfnahmen
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Bekanntmachung \u00fcber die...
Corporate News
20.05.2021 |
APONTIS PHARMA AG Trading Update: Starkes Umsatz- und Ergebniswachstum mit Single Pills setzt sich...
APONTIS PHARMA AG / Schlagwort(e): Quartals-/Zwischenmitteilung APONTIS PHARMA AG Trading Update: Starkes...
Corporate News
20.05.2021 | DGAP-News
APONTIS PHARMA AG Trading Update: Strong revenues and earnings growth with Single Pills continues...
DGAP-News: APONTIS PHARMA AG/ Key word(s): Quarterly/ Interim Statement 20.05.2021/ 07:30 The issuer is solely...
Corporate News
19.05.2021 |
APONTIS PHARMA AG: Bekanntmachung \u00fcber die Durchf\u00fchrung von Stabilisierungsma\u00dfnahmen
APONTIS PHARMA AG / Schlagwort(e): Sonstiges APONTIS PHARMA AG: Bekanntmachung \u00fcber die...
Corporate News
19.05.2021 | DGAP-News
APONTIS PHARMA AG: Notification on the implementation of stabilization measures
DGAP-News: APONTIS PHARMA AG/ Key word(s): Miscellaneous 19.05.2021/ 20:23 The issuer is solely responsible for the...
Corporate News
14.05.2021 | EQS-News
Apontis Pharma (APPH): Initiation - A phoenix rises
Edison Investment Research Limited 14-May-2021/ 07:00 GMT/BST London, UK, 14 May 2021 Apontis...
Corporate News
06.05.2021 |
APONTIS PHARMA AG legt Platzierungspreis f\u00fcr ihren B\u00f6rsengang auf EUR 19,00 je Aktie fest
APONTIS PHARMA AG / Schlagwort(e): B\u00f6rsengang APONTIS PHARMA AG legt Platzierungspreis f\u00fcr ihren...
Corporate News
06.05.2021 | DGAP-News
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 06.05.2021/ 20:09 The issuer is solely responsible for the content of...
Ad-hoc News
06.05.2021 |
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG / Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share...
Ad-hoc News
06.05.2021 | DGAP-Ad-hoc
APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share
APONTIS PHARMA AG/ Key word(s): IPO APONTIS PHARMA AG sets placement price for its IPO at EUR 19.00 per share...
Corporate News
29.04.2021 |
APONTIS PHARMA AG legt Preisspanne f\u00fcr geplanten B\u00f6rsengang auf EUR 18,50 bis EUR 24,50...
APONTIS PHARMA AG / Schlagwort(e): B\u00f6rsengang APONTIS PHARMA AG legt Preisspanne f\u00fcr geplanten...
Corporate News
29.04.2021 | DGAP-News
APONTIS PHARMA AG sets price range for planned IPO between EUR 18.50 and EUR 24.50 per share
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 29.04.2021/ 08:30 The issuer is solely responsible for the content of...
Corporate News
21.04.2021 | DGAP-News
APONTIS PHARMA plans initial public offering
DGAP-News: APONTIS PHARMA AG/ Key word(s): IPO 21.04.2021/ 08:30 The issuer is solely responsible for the content of...
Corporate News
21.04.2021 |
APONTIS PHARMA plant B\u00f6rsengang
APONTIS PHARMA AG / Schlagwort(e): B\u00f6rsengang APONTIS PHARMA plant B\u00f6rsengang 21.04.2021...
Sven Pauly
Thank you very much,
we have received your message
and will contact you shortly!
we have received your message
and will contact you shortly!